Patents by Inventor Mary Guttieri

Mary Guttieri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antiviral rift valley fever virus peptides and methods of use
    Patent number: 9556237
    Abstract: The invention entails synthetic short peptides based on Rift Valley Fever Virus (RVFV) fusion protein. The peptides are broad-spectrum antivirals, and are useful for prophylactic treatment against or therapeutic treatment of infection by hemorrhagic fever viruses, such as RVFV, Ebola Virus, and Andes Virus, as well as vesicular stomatitis virus.
    Type: Grant
    Filed: June 4, 2015
    Date of Patent: January 31, 2017
    Assignee: The United States of America, as represented by the Secretary of the Army, on behalf of the U.S. Army Medical Research Institute of Infectious Diseases
    Inventors: Connie Schmaljohn, Robert F. Garry, Jeffrey W. Koehler, Mary Guttieri
  • ANTIVIRAL RIFT VALLEY FEVER VIRUS PEPTIDES AND METHODS OF USE
    Publication number: 20150337015
    Abstract: The invention entails synthetic short peptides based on Rift Valley Fever Virus (RVFV) fusion protein. The peptides are broad-spectrum antivirals, and are useful for prophylactic treatment against or therapeutic treatment of infection by hemorrhagic fever viruses, such as RVFV, Ebola Virus, and Andes Virus, as well as vesicular stomatitis virus.
    Type: Application
    Filed: June 4, 2015
    Publication date: November 26, 2015
    Applicant: The United States of America, as represented by the Secretary of the Army, on behalf of the United
    Inventors: CONNIE SCHMALJOHN, Robert F. Garry, Jeffrey W. Koehler, Mary Guttieri